What This FDA News Could Mean for AbbVie's Stock

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jan 24, 2022 at 10:22 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,741
    Likes Received:
    3
    via
    • If approved, Rinvoq would gain access to nearly 200,000 potential patients.
    • The indication could generate $500 million in annual revenue for AbbVie.
    • AbbVie still looks like a great dividend growth stock for income investors.

    article source